旁观者心肺复苏对院外心脏骤停医院费用及长期生存的影响
该研究为回顾性队列研究,纳入2001至2010年华盛顿州金县EMS救治的连续院外心脏骤停患者(≥12岁,在EMS到达前且不在护理机构内发生),共4448例。旁观者心肺复苏组5年生存率为14.3%,未接受组为8.7%(p<0.001),平均增加0.09个质量调整生命年。所有入院患者初始急性住院平均总费用为19961美元(标准差40498),5年存活者为75175美元(标准差52276)。旁观者心肺复苏的增量成本效果比为每质量调整生命年48044美元,作者认为其与长期生存正相关且似乎具有成本效果。
要点
- 在4448例EMS救治的院外心脏骤停患者中,接受旁观者心肺复苏者5年生存率为14.3%,未接受者为8.7%(p<0.001)。
- 旁观者心肺复苏平均增加0.09个质量调整生命年,增量成本效果比为每质量调整生命年48044美元。
- 所有入院患者初始急性住院平均总费用为19961美元(标准差40498),5年存活者为75175美元(标准差52276)。
- 作者认为旁观者心肺复苏与长期生存正相关,且似乎具有成本效果。
适用人群与场景
- 2001至2010年华盛顿州金县EMS救治的连续院外心脏骤停患者,年龄≥12岁,在EMS到达前且不在护理机构内发生心脏骤停。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入4448例符合条件的患者,18.5%(n=824)存活出院,12.1%(n=539)5年时存活。
- 接受旁观者心肺复苏者5年生存率为14.3%,未接受者为8.7%(p<0.001),平均增加0.09个质量调整生命年。
- 所有入院患者初始急性住院平均总费用为19961美元(标准差40498),5年存活者为75175美元(标准差52276)。
- 旁观者心肺复苏的增量成本效果比为每质量调整生命年48044美元。
证据类型、等级与局限
- 证据类型为回顾性队列研究;作者结论认为旁观者心肺复苏与长期生存正相关且似乎具有成本效果。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为旁观者心肺复苏与院外心脏骤停患者长期生存正相关,且似乎具有成本效果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Bystander cardiopulmonary resuscitation (CPR) is associated with a greater likelihood of survival to hospital discharge after out-of-hospital cardiac arrest (OHCA). However the long-term survival benefits in relationship to cost have not been well-studied. We evaluated bystander CPR, hospital-based costs, and long-term survival following OHCA in order to assess the potential cost-effectiveness of bystander CPR.
PATIENTS AND METHODS: We conducted a retrospective cohort study of consecutive EMS-treated OHCA patients >=12years who arrested prior to EMS arrival and outside a nursing facility between 2001 and 2010 in greater King County, WA. Utstein-style information was obtained from the EMS registry, including 5-year survival. Costs from the OHCA hospitalization were obtained from the Washington State Comprehensive Hospital Abstract Reporting System. Cost effectiveness was based on hospital costs divided by quality-adjusted life years (QALYs) for a 5-year follow-up window.
RESULTS: Of the 4448 eligible patients, 18.5% (n=824) were discharged alive from hospital and 12.1% (n=539) were alive at 5 years. Five-year survival was higher in patients who received bystander CPR (14.3% vs. 8.7%, p<0.001) translating to an average 0.09 QALYs associated with bystander CPR. The average (SD) total cost of the initial acute care hospitalization was USD 19,961 (40,498) for all admitted patients and USD 75,175 (52,276) for patients alive at year 5. The incremental cost-effectiveness ratio associated with bystander CPR was USD 48,044 per QALY.
CONCLUSION: Based on this population-based investigation, bystander CPR was positively associated with long-term survival and appears cost-effective.
参考来源
- Geri G, Fahrenbruch C, Meischke H, et al. Effects of bystander CPR following out-of-hospital cardiac arrest on hospital costs and long-term survival. Resuscitation. 2017. PMID: 28427882. doi:10.1016/j.resuscitation.2017.04.016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。